Alison Long

Alison Long

Director/Miembro de la Junta en TAYSHA GENE THERAPIES, INC. .

Fortuna: 746 535 $ al 31/05/2026

63 años
Health Technology
Consumer Services

Perfil

Dr. Alison Long is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Medical Officer at Flightpath Biosciences, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Long was previously employed as a Chief Medical Officer by Anokion SA, a Chief Medical Officer by Kaleido Biosciences, Inc., a Chief Medical Officer by Freeline Therapeutics Holdings Ltd., and a Head-Clinical R&D by Spark Therapeutics, Inc. She received her undergraduate degree from the University of the Witwatersrand and a doctorate degree from George Mason University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/06/2026 127.178 ( 0,05 % ) 746 535 $ 31/05/2026

Cargos activos de Alison Long

EmpresasCargoInicio
TAYSHA GENE THERAPIES, INC. Director/Miembro de la Junta 01/11/2023
Director Técnico/Científico/I+D 01/01/2023

Antiguos cargos conocidos de Alison Long.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/01/2023
KALEIDO BIOSCIENCES, INC. Director Técnico/Científico/I+D 01/04/2022
FREELINE THERAPEUTICS HOLDINGS PLC Director Técnico/Científico/I+D 01/11/2021
SPARK THERAPEUTICS, INC. Director Técnico/Científico/I+D 01/06/2020
Ver el detalle de la experiencia de Alison Long.

Formación de Alison Long.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

13

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology